DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury
NCT04447404
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
2
Enrollment
INDUSTRY
Sponsor class
Stopped
low enrollment
Conditions
SARS-CoV-2
Interventions
DRUG:
DUR-928
DRUG:
Placebo
Sponsor
Durect